Omkar Pharmachem Corporate Filings & Announcements

Latest corporate announcements and filings from Omkar Pharmachem on BSE

Search Inside the pdf :

15 Nov 2025

Company Update

Omkar Pharmachem Ltd - 532167 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Dear Sir, Please find newspaper Advertisement of Unaudited Financial Statement for the Quarter & half yearly ended on 30.09.2025.

pdf

Omkar Pharmachem Ltd.

14 Nov 2025

Result

Omkar Pharmachem Ltd - 532167 - Results- Unaudited Financial Results For September, 2025

BSE India

Unaudited Financial Results for the Quarter and Half yearly ended on 30th September, 2025

pdf

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	0.14	0.14	0.14	0.0%	0.0%
Operating Profit Qtr	0.07	0.04	0.09	75.0%	-22.2%
Net Profit Qtr	0.05	0.03	0.09	66.7%	-44.4%
Earning Per Share Adjusted latest Qtr	0.05	0.03	0.09	66.7%	-44.4%

* Standalone data

Detailed Results

Omkar Pharmachem Ltd.

14 Nov 2025

Board Meeting

Omkar Pharmachem Ltd - 532167 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 14th November, 2025 has considered and approved the following business: 1. Unaudited Financial Results of the Company for the quarter and half yearly ended on 30th September, 2025

pdf

Omkar Pharmachem Ltd.

06 Nov 2025

Board Meeting

Omkar Pharmachem Ltd - 532167 - Board Meeting Intimation for Board Meeting Intimation For Inter-Alia, To …

BSE India

Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Unaudited Standalone Financial Results Of The Company For The Quarter & Half Yearly Ended September 30, 2025.

pdf

Omkar Pharmachem Ltd.

28 Oct 2025

Company Update

Omkar Pharmachem Ltd - 532167 - Report On Action Taken Under The Special Window For Re-Lodgement …

BSE India

Dear Sir/Ma''am, Please find enclosed report on action under the Special Window for re-lodgement of transfer requests for the month of September, 2025

pdf

Omkar Pharmachem Ltd.

15 Oct 2025

Company Update

Omkar Pharmachem Ltd - 532167 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Dear Sir, Please find Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the Quarter ended 30.09.2025.

pdf

Omkar Pharmachem Ltd.

27 Sep 2025

SAST

Omkar Pharmachem Ltd - 532167 - Closure of Trading Window

BSE India

Dear Sir, Pursuant to SEBI(LODR) Regulations, 2015 as amended and the Company''s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities shall remain closed for all the designated persons and their immediate relatives from Wednesday, 01.10.2025 till the expiry of 48 hours after the declaration of Unaudited Financial Results for the Quarter and Half Yearly ended on September 30, 2025.

pdf

Omkar Pharmachem Ltd.

25 Sep 2025

AGM

Omkar Pharmachem Ltd - 532167 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Voting Results of 30th AGM of the Company in terms of Reg 44(3) of SEBI(LODR) Regulations, 2015 alongwith Consolidated Scrutinizer Report

pdf

Omkar Pharmachem Ltd.

24 Sep 2025

AGM

Omkar Pharmachem Ltd - 532167 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Proceeding of 30th Annual General Meeting of the Omkar Pharmachem Limited held on 24th September, 2025

pdf

Omkar Pharmachem Ltd.

05 Sep 2025

Company Update

Omkar Pharmachem Ltd - 532167 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Dear Sir/Ma''am, Please find Newspaper Publication in respect of opening of special window for Re-lodgement of transfer requests of physical shares of the company.

pdf

Is Omkar Pharmachem Ltd. worth buying?

2 Votes:

Buy 100.0%